HMOX1 and pulmonary arterial hypertension: In addition, the cholesterol-lowering drug simvastatin defends against the development of pulmonary hypertension and ameliorates established pulmonary hypertension via an HO-1-dependent pathway in rodent models of PAH [128,129].